| Name | Walgreens #17879 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 3891 Route 516, Old Bridge, New Jersey 08857 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (732) 607-7510 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
POZEN Inc. announced today the results of a Phase I study that showed a novel, investigational combination of enteric-coated aspirin (EC-ASA) and immediate-release omeprazole known as PA65020, is associated with a significantly decreased risk of GI mucosal damage compared to analgesic doses (650 mg twice daily) of over-the-counter enteric-coated aspirin (EC-ASA) in healthy adults treated for one month.
While falls are a common cause of injury, particularly in older, hospitalized patients, some may not be as preventable as once thought. According to a new literature review published in the Journal of the American Academy of Orthopaedic Surgeons, many of the risks that frequently cause falls are not adequately addressed with the fall prevention initiatives used in healthcare facilities.
A study shows for the first time that people with cirrhosis who receive mRNA COVID-19 vaccination gain important protection against more serious outcomes like hospitalization and death. At the same time, however, the vaccines offer less protection against SARS-CoV-2 infection and take longer to take effect in this population.
In tumor immunotherapy, the body's own defense system is activated against the tumor cells. However, for the majority of patients, the tumor cells become resistant to the treatments used.
› Verified 1 days ago
| NPI Number | 1124543913 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #17879 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3891 Route 516, Old Bridge, NJ 08857 |
| Phone Number | 732-607-7510 |
News Archive
POZEN Inc. announced today the results of a Phase I study that showed a novel, investigational combination of enteric-coated aspirin (EC-ASA) and immediate-release omeprazole known as PA65020, is associated with a significantly decreased risk of GI mucosal damage compared to analgesic doses (650 mg twice daily) of over-the-counter enteric-coated aspirin (EC-ASA) in healthy adults treated for one month.
While falls are a common cause of injury, particularly in older, hospitalized patients, some may not be as preventable as once thought. According to a new literature review published in the Journal of the American Academy of Orthopaedic Surgeons, many of the risks that frequently cause falls are not adequately addressed with the fall prevention initiatives used in healthcare facilities.
A study shows for the first time that people with cirrhosis who receive mRNA COVID-19 vaccination gain important protection against more serious outcomes like hospitalization and death. At the same time, however, the vaccines offer less protection against SARS-CoV-2 infection and take longer to take effect in this population.
In tumor immunotherapy, the body's own defense system is activated against the tumor cells. However, for the majority of patients, the tumor cells become resistant to the treatments used.
› Verified 1 days ago
| NPI Number | 1851810642 |
| Organization Name | WALGREEN CO |
| Doing Business As | RITE AID |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3891 Route 516, Old Bridge, NJ 08857 |
| Phone Number | 732-607-7510 |
News Archive
POZEN Inc. announced today the results of a Phase I study that showed a novel, investigational combination of enteric-coated aspirin (EC-ASA) and immediate-release omeprazole known as PA65020, is associated with a significantly decreased risk of GI mucosal damage compared to analgesic doses (650 mg twice daily) of over-the-counter enteric-coated aspirin (EC-ASA) in healthy adults treated for one month.
While falls are a common cause of injury, particularly in older, hospitalized patients, some may not be as preventable as once thought. According to a new literature review published in the Journal of the American Academy of Orthopaedic Surgeons, many of the risks that frequently cause falls are not adequately addressed with the fall prevention initiatives used in healthcare facilities.
A study shows for the first time that people with cirrhosis who receive mRNA COVID-19 vaccination gain important protection against more serious outcomes like hospitalization and death. At the same time, however, the vaccines offer less protection against SARS-CoV-2 infection and take longer to take effect in this population.
In tumor immunotherapy, the body's own defense system is activated against the tumor cells. However, for the majority of patients, the tumor cells become resistant to the treatments used.
› Verified 1 days ago
News Archive
POZEN Inc. announced today the results of a Phase I study that showed a novel, investigational combination of enteric-coated aspirin (EC-ASA) and immediate-release omeprazole known as PA65020, is associated with a significantly decreased risk of GI mucosal damage compared to analgesic doses (650 mg twice daily) of over-the-counter enteric-coated aspirin (EC-ASA) in healthy adults treated for one month.
While falls are a common cause of injury, particularly in older, hospitalized patients, some may not be as preventable as once thought. According to a new literature review published in the Journal of the American Academy of Orthopaedic Surgeons, many of the risks that frequently cause falls are not adequately addressed with the fall prevention initiatives used in healthcare facilities.
A study shows for the first time that people with cirrhosis who receive mRNA COVID-19 vaccination gain important protection against more serious outcomes like hospitalization and death. At the same time, however, the vaccines offer less protection against SARS-CoV-2 infection and take longer to take effect in this population.
In tumor immunotherapy, the body's own defense system is activated against the tumor cells. However, for the majority of patients, the tumor cells become resistant to the treatments used.
› Verified 1 days ago
Acme Pharmacy #2827 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3500 Us Highway 9, Old Bridge, New Jersey 08857 Phone: (732) 607-9260 | |
Future Pharmacy Ii Llc Type: Community/Retail Pharmacy Location: 72 Route 34, Old Bridge, New Jersey 08857 Phone: (732) 952-5550 | |
Cvs Pharmacy #02139 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2988 Route 516 And Red Oak Ln, Old Bridge, New Jersey 08857 Phone: (732) 607-2941 | |
The Wellness Center Pharmacy & Surg Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3117 Us Highway 9, Old Bridge, New Jersey 08857 Phone: (732) 679-3555 | |
Shoprite Pharmacy Of Old Bridge Type: Pharmacy Location: 2239 Route 9, Old Bridge, New Jersey 08857 Phone: (732) 727-3534 |